Farms.com Home   News

July shows slight dip in US milk supply

Aug 26, 2024
By Farms.com

USDA notes minor decrease in July milk production

 

Recently the USDA highlighted a slight downturn in the U.S. milk production, recording a marginal year-over-year decrease of 0.2 percent to 18.2 billion pounds.

This decline was observed even though there was an incremental rise in milk production per cow, which increased to 2,047 pounds. The total count of dairy cows saw a reduction, coming in at 8.88 million, which is 31,000 less than the previous year.

Revisions to June's milk production statistics also reflect a downward trend, with a 1.5 percent decrease compared to last year, culminating in 17.9 billion pounds.

The three-month period ending in June saw the dairy herd size reduce to 9.33 million from 9.41 million, with a slight dip in production per cow.

The U.S. milk production for July summed up to 18.9 billion pounds, indicating a 0.4 percent decline from the prior year. These statistics underline the subtle yet impactful shifts within the dairy industry, which are essential for stakeholders aiming to navigate the complexities of market demand and supply dynamics effectively.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.